Viewing StudyNCT00553618



Ignite Creation Date: 2024-05-05 @ 6:51 PM
Last Modification Date: 2024-10-26 @ 9:37 AM
Study NCT ID: NCT00553618
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2021-10-29
First Post: 2007-11-01

Brief Title: Adjuvant Combined Interleukin 2 Proleukin and DTIC Dacarbazine in High-risk Melanoma Patients
Sponsor: University of Louisville
Organization: University of Louisville

Organization Data

Organization: University of Louisville
Class: OTHER
Study ID: 070008
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Louisville
Lead Sponsor Class: OTHER
Responsible Party: Jason Chesney
Responsible Party Title: Director James Graham Brown Cancer Center
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: University of Louisville
Old Name: None
Old Organization: None

Collaborators

Name Class
James Graham Brown Cancer Center OTHER